Genetic and Clinical Features of P450 Oxidoreductase Deficiency
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
P450 oxidoreductase (POR) deficiency is an autosomal recessive disorder of steroidogenesis with multiple clinical manifestations. POR is the electron donor for all microsomal P450 enzymes, including the three steroidogenic enzymes P450c17 (17α-hydroxylase/17,20-lyase), P450c21 (21-hydroxylase), and P450aro (aromatase). Since the first description of POR mutations in 2004, about 50 patients have been reported. Serum steroid profiles indicate partial deficiencies in 21-hydroxylase, 17α-hydroxylase and 17,20-lyase. The 17-OH progesterone levels are elevated, as in 21-hydroxylase deficiency, while androgen levels are low; cortisol may be normal but is poorly responsive to adrenocorticotropic hormone. Most patients also have associated skeletal malfor- mations (craniosynostosis, radio-ulnar synostosis, midface hypoplasia, bowed femora) termed Antley-Bixler syndrome. Antley-Bixler syndrome with normal steroidogenesis is caused by autosomal dominant gain-of-function mutations in fibroblast growth factor receptor 2. Males with POR deficiency are often undervirilized, while females can be virilized. The prognosis for patients with POR deficiency appears to depend on the severity of the bony malformations and their timely treatment. The potential impact of POR mutations on drug metabolism by other hepatic P450 enzymes requires further investigation. Given the varied physical and biochemical phenotype of POR deficiency and the risk of adrenal insufficiency, clinicians should be alert to this potential diagnosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over 50 POR mutations have now been described, affecting various P450 enzymes to differing degrees, apparently explaining the great variability in the clinical and hormonal findings in POR deficiency (305,319).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [319]
In the citing paper
“Despite its embryonic lethality in mice, POR deficiency is a newly recognized form of CAH (305, 314 -319).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [319]
In the citing paper
“The incidence of POR deficiency is unknown; the rapid description of large numbers of patients (305, 319) and the potentially very subtle clinical manifestations in individuals carrying mutations with partial activity (283,305,314,335) suggest that POR deficiency may be fairly common.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [319]
Citations
Cites
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Recommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome
Reardon, W., Winter, R. M., Rutland, P., Pulleyn, L. J., Jones, B. M., & Malcolm, S. (1994) · Nature Genetics · doi:10.1038/ng0994-98 · Cited by 758
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-269 · Cited by 614 · cited 1×
“FGFs can bind four different tyrosine kinase cell surface receptors (FGFRs). Dominant gain-of-function mutations in FGFRs (primarily FGFR2) cause a number of phenotypically diverse craniosynostosis syndromes, including Pfeiffer, Apert, Jackson-Weiss, and Crouzon syndromes [”
BackgroundCytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509 · cited 1×
“and the recently described P450 oxidoreductase (POR) deficiency [”
BackgroundSelf-citationIdentical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes
Rutland, P., Pulleyn, L. J., Reardon, W., Baraitser, M., Hayward, R., Jones, B., Malcolm, S., Winter, R. M., Oldridge, M., Slaney, S. F., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-173 · Cited by 451
The backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Research works printed but not linked: 4
- 10.1074%2Fjbc.271.11.6483 · DOI · Paper page
- 10.1210%2Fme.13.1.167 · doi:10.1210/me.13.1.167 · Paper page
- 10.1097%2F00006454-199211120-00017 · DOI
- 10.1210%2Fme.13.7.1169 · doi:10.1210/me.13.7.1169 · Paper page
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationMalformation syndromes caused by disorders of cholesterol synthesis
Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473
46,XY disorders of sex development (DSD)
Mendonca, B. B., Domenice, S., Arnhold, I. J. P., & Costa, E. M. F. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03392.x · Cited by 204
Laue, K., Pogoda, H.-M., Daniel, P. B., van Haeringen, A., Alanay, Y., von Ameln, S., Rachwalski, M., Morgan, T., Gray, M. J., Breuning, M. H., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.09.015 · Cited by 188
Aromatase deficiency in men: a clinical perspective
Rochira, V., & Carani, C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.176 · Cited by 134
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 136
Self-citationTherapeutic perspectives of epigenetically active nutrients
Remely, M., Lovrecic, L., de la Garza, A. L., Migliore, L., Peterlin, B., Milagro, F. I., Martinez, A. J., & Haslberger, A. G. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12854 · Cited by 126
Fukami, M., Nishimura, G., Homma, K., Nagai, T., Hanaki, K., Uematsu, A., Ishii, T., Numakura, C., Sawada, H., Nakacho, M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2816 · Cited by 117
Agrawal, V., Huang, N., & Miller, W. L. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32830054ac · Cited by 117
Self-citationFukami, M., Homma, K., Hasegawa, T., & Ogata, T. (2013) · Developmental Dynamics · doi:10.1002/dvdy.23892 · Cited by 114
Malformation syndromes associated with disorders of sex development
Hutson, J. M., Grover, S. R., O’Connell, M. A., & Pennell, S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.83 · Cited by 110
Consequences of POR mutations and polymorphisms
Miller, W. L., Agrawal, V., Sandee, D., Tee, M. K., Huang, N., Choi, J. H., Morrissey, K., & Giacomini, K. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.10.022 · Cited by 88
Self-citationClinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients
Sahakitrungruang, T., Huang, N., Tee, M. K., Agrawal, V., Russell, W. E., Crock, P., Murphy, N., Migeon, C. J., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1460 · Cited by 82
Self-citationDi Dalmazi, G., Fanelli, F., Mezzullo, M., Casadio, E., Rinaldi, E., Garelli, S., Giampalma, E., Mosconi, C., Golfieri, R., Vicennati, V., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1992 · Cited by 82
“The first possibility relies on a reduced 17,20 lyase activity of P450c17, as an intrinsic characteristic of adrenocortical adenomas.”
BackgroundInfluentialΚousta, E., Papathanasiou, A., & Skordis, N. (2010) · HORMONES · doi:10.14310/horm.2002.1272 · Cited by 86
Baronio, F., Ortolano, R., Menabò, S., Cassio, A., Baldazzi, L., Natale, V. D., Tonti, G., Vestrucci, B., & Balsamo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184605 · Cited by 60
Fukami, M., & Ogata, T. (2014) · Pediatrics International · doi:10.1111/ped.12518 · Cited by 56
Genetic variation in human P450 oxidoreductase
Miller, W. L., Huang, N., Agrawal, V., & Giacomini, K. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.017 · Cited by 54
“Thus he human POR gene contains 16 exons spanning 73.2 kb. Studies with nearly 50 patients with POR deficiency (reviewed n Scott and Miller, 2008) lead to the following conclusions.”
BackgroundInfluentialSelf-citation46,XY Disorders of Sexual Development
Domenice, S., Arnhold, I. J. P., Costa, E. M. F., & Mendonca, B. B. (2013) · Europe PMC (PubMed Central) · Cited by 52
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Self-citationAdrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Self-citationMultigene Predictors of Tacrolimus Exposure in Kidney Transplant Recipients
Pulk, R., Schladt, D. P., Oetting, W. S., Guan, W., Israni, A. K., Matas, A. J., Remmel, R. P., Jacobson, P. A., & for the DeKAF Investigators (2015) · Pharmacogenomics · doi:10.2217/pgs.15.42 · Cited by 39
Ha, Y. W., Moon, J., Jung, H., Chung, B. C., & Choi, M. H. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.11.010 · Cited by 35
Cytochrome P450 Oxidoreductase Deficiency
Idkowiak, J., Cragun, D. L., Hopkin, R. J., & Arlt, W. (2009) · University of Washington, Seattle eBooks · Cited by 33
Papadakis, G. E., Dumont, A., Bouligand, J., Chasseloup, F., Raggi, A., Catteau-Jonard, S., Boute‐Bénéjean, O., Pitteloud, N., Young, J., & Dewailly, D. (2020) · Human Reproduction · doi:10.1093/humrep/deaa020 · Cited by 38
Classic and backdoor pathways of androgen biosynthesis in human sexual development
Lee, H. G., & Kim, C. J. (2022) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2244124.062 · Cited by 42
Fukami, M., Nagai, T., Mochizuki, H., Muroya, K., Yamada, G., Takitani, K., & Ogata, T. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.03.023 · Cited by 30
Clinical and molecular review of atypical congenital adrenal hyperplasia
Sahakitrungruang, T. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.1.1 · Cited by 30
Jeandron, D. D., & Sahakitrungruang, T. (2012) · Hormone Research in Paediatrics · doi:10.1159/000336004 · Cited by 27
Chen, C., Shan, T., Liu, Y., Shi, X., & Gao, X. (2018) · Pest Management Science · doi:10.1002/ps.5208 · Cited by 26
Malik, A. I., Rowan‐Carroll, A., Williams, A., Lemieux, C. L., Long, A. S., Arlt, V. M., Phillips, D. H., White, P. A., & Yauk, C. L. (2013) · Mutagenesis · doi:10.1093/mutage/get031 · Cited by 27
Song, T., Wang, B., Chen, H., Zhu, J., & Sun, H. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1393663 · Cited by 24
Biason‐Lauber, A., Boscaro, M., Mantero, F., & Balercia, G. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346683 · Cited by 25
Biallelic mutations in CYP26B1 : A differential diagnosis for Pfeiffer and Antley–Bixler syndromes
Morton, J. E. V., Frentz, S., Morgan, T., Sutherland‐Smith, A. J., & Robertson, S. P. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37804 · Cited by 24
Soneda, S., Yazawa, T., Fukami, M., Adachi, M., Mizota, M., Fujieda, K., Miyamoto, K., & Ogata, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1337 · Cited by 23
Congenital adrenal hyperplasia
Demirci, C., & Witchel, S. F. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00216.x · Cited by 24
Fan, L., Ren, X., Song, Y., Su, C., Fu, J., & Gong, C. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1283-2 · Cited by 22
46,XY disorders of sex development (DSD)
Mendonca, B. B., Domenice, S., Arnhold, I. J. P., & Costa, E. M. F. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02993.x-i1 · Cited by 43
Aguilar, A., Wu, S., & De Luca, F. (2009) · Endocrinology · doi:10.1210/en.2009-0043 · Cited by 21
Bonamichi, B. D. S. F., Santiago, S. L. M., Bertola, D. R., Kim, C. A., Alonso, N., Mendonca, B. B., Bachega, T. A. S. S., & Gomes, L. G. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000213 · Cited by 19
“Patients with PORD may also exhibit bone defects that are characteristics of Antley-Bixler syndrome because of the impairment of enzymes involved in the sterol synthesis pathway, such as lanosterol 14a-demethylase (CYP51A1), and enzymes involved in retinoic acid metabolism (CYP26) (11).”
BackgroundComplete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation
Vonada, A., Wakefield, L., Martinez, M. A., Harding, C. O., Grompe, M., & Tiyaboonchai, A. (2023) · Hepatology · doi:10.1097/hep.0000000000000631 · Cited by 5
Disorders of Sex Development: Neonatal Diagnosis and Management
Paris, F., Gaspari, L., Philibert, P., Maïmoun, L., Kalfa, N., & Sultan, C. (2012) · Endocrine development · doi:10.1159/000326631 · Cited by 23
Zhang, T., Li, Z., Ren, X., Huang, B., Zhu, G., Yang, W., & Jin, L. (2020) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-020-01899-z · Cited by 24
Guaragna-Filho, G., Castro, C. C. T. D. S., De Carvalho, R. R., Coeli, F. B., Ferraz, L. F. C., Petroli, R. J., De Mello, M. P., Sewaybricker, L. E., Lemos-Marini, S. H. V., D'Souza-Li, L. F. R., et al. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000800020 · Cited by 18
Arboleda, V. A., Fleming, A. A., & Vilain, E. J. N. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00021-3 · Cited by 20
Alberola, T. M., Bautista-Llácer, R., Fernández, E., Vendrell, X., & Pérez‐Alonso, M. (2009) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-009-9327-5 · Cited by 18
Tomková, M., Marohnic, C. C., Gurwitz, D., Šeda, O., Masters, B. S. S., & Martásek, P. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.21 · Cited by 17
Lv, J., Hu, L., Zhuo, W., Zhang, C., Zhou, H., & Fan, L. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000190 · Cited by 19
Biological Application and Disease of Oxidoreductase Enzymes
Habte, M. L., & Beyene, E. A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93328 · Cited by 14
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 37
Self-citationTzetis, M., Konstantinidou, A. E., Sofocleous, C., Kosma, K., Mitrakos, A. K., Tzannatos, C. A., & Kitsiou‐Tzeli, S. (2016) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23492 · Cited by 16
Greaves, R. F., Kumar, M., Mawad, N., Francescon, A., Le, X. C., O’Connell, M. A., Chi, J., & Pitt, J. J. (2023) · International Journal of Neonatal Screening · doi:10.3390/ijns9040058 · Cited by 13
Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency
Koika, V., Armeni, A. K., & Georgopoulos, N. A. (2016) · HORMONES · doi:10.14310/horm.2002.1679 · Cited by 14
Arboleda, V. A., & Vilain, E. J. N. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00016-4 · Cited by 13
An Investigation of Steroid Biosynthesis Pathway Genes in Women with Polycystic Ovary Syndrome
Sharma, P., Jain, M., & Halder, A. (2022) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_86_22 · Cited by 14
Wang, C., & Tian, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1226387 · Cited by 11
Sánchez-Garvín, D., Albaladejo, S., Ezquieta, B., & Corripio, R. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-010251 · Cited by 13
P450 oxidoreductase deficiency with maternal virilization during pregnancy
Nakanishi, K., Yamashita, A., Miyamoto, T., Takeguch, R., Furuya, A., Matsuo, K., Tanahashi, Y., Kawamura, M., & Sengoku, K. (2016) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog3172.2016 · Cited by 13
Witchel, S. F., & Plant, T. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00018-4 · Cited by 12
Abderahmene, A., Khalij, Y., Moussa, A., Ammar, M., Ellouz, A., Amor, D., Abbes, H., Ganouni, M. R., SAHTOUT, W., Chouchène, S., et al. (2024) · The Pharmacogenomics Journal · doi:10.1038/s41397-024-00323-4 · Cited by 9
Ono, H., Numakura, C., Homma, K., Hasegawa, T., Tsutsumi, S., Kato, F., Fujisawa, Y., Fukami, M., & Ogata, T. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.12.008 · Cited by 9
Zlotnik, D., Rabinski, T., Halfon, A., Anzi, S., Plaschkes, I., Benyamini, H., Nevo, Y., Gershoni, O. Y., Rosental, B., Hershkovitz, E., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.07.010 · Cited by 12
Lin, C., Cheng, L., Lin, T.-C. E., Wang, C.-J., & Li, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.05.013 · Cited by 9
Craniosynostosis and Chromosomal Alterations
Passos‐Bueno, M. R., Fanganiello, R. D., & Jehee, F. S. (2011) · Monographs in human genetics · doi:10.1159/000319987 · Cited by 9
In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase
Nurhafizuddin, M., Azizi, A., Ming, L. C., & Shafqat, N. (2022) · Molecules · doi:10.3390/molecules27144646 · Cited by 8
Congenital Adrenal Hyperplasia
Trapp, C. M., Levine, L. S., & Oberfield, S. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_14 · Cited by 8
Congenital Adrenal Hyperplasia: An Endocrine Disorder with Neonatal Onset
STOKOWSKI, L. A. (2009) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2009.01.008 · Cited by 7
Congenital adrenal hyperplasia
Krone, N. P., & Hughes, I. A. (2020) · doi:10.1093/med/9780198746690.003.0250 · Cited by 8
Li, Y., Zhang, C., & Zhang, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1019696 · Cited by 9
Aljabri, A., Alnaim, F. S., & Alsaleh, Y. (2020) · BMJ Case Reports · doi:10.1136/bcr-2019-233942 · Cited by 8
Anomalías de la diferenciación sexual
Audí, L. (2011) · Anales de Pediatría Continuada · doi:10.1016/s1696-2818(11)70003-8 · Cited by 10
Arboleda, V. A., & Vilain, E. J. N. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00017-2 · Cited by 6
Targeted Metabolite Profiling: Sample Preparation Techniques for GC-MSBased Steroid Analysis
Sadanala, K. C., Lee, J., Chung, B. C., & Choi, M. H. (2012) · Mass spectrometry letters · doi:10.5478/msl.2012.3.1.004 · Cited by 6
Congenital adrenal hyperplasia and hypertension
Tosun, B. G., & Güran, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00015-7 · Cited by 6
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00096-4 · Cited by 6
Self-citationDisorders in Male Sexual Differentiation: Molecular Genetics, Gender Identity, and Cognition
Zhu, Y., & Imperato‐McGinley, J. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00088-7 · Cited by 6
Zhu, Y., & Imperato‐McGinley, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00067-5 · Cited by 6
Did Akhenaten Have the Antley–Bixler Syndrome?
Miller, W. L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-12-200912150-00012 · Cited by 4
Self-citationDélot, E. C., & Vilain, E. J. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00016-0 · Cited by 5
Guo, X., Wang, D., Shan, X., Yang, L., Ding, Y., Chen, H., Rong, X., Chu, M., Lin, J. J., & Chen, C. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102261 · Cited by 2
Disorders of the Adrenal Gland
Fechner, P. Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00096-6 · Cited by 3
Disorders of Sexual Development
Balsamo, A., Cicognani, A., Ghirri, P., Scaramuzzo, R. T., D’Alberton, F., Bertelloni, S., & Boldrini, A. (2012) · Springer eBooks · doi:10.1007/978-88-470-1405-3_123 · Cited by 2
Metabolic and endocrine disorders
Martin, R. J., Fanaroff, A. A., & Walsh, M. C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06545-0.00058-3 · Cited by 3
Primäre Nebenniereninsuffizienz bei Kindern und Jugendlichen
Kamrath, C., & Riepe, F. G. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-57309-9_34 · Cited by 2
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00097-4 · Cited by 3
Self-citationDisorders of the Adrenal Gland
Nimkarn, S., & New, M. I. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0134-0.10091-5 · Cited by 3
Witchel, S. F., & Plant, T. M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00017-6 · Cited by 4
Anaforoğlu, İ. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_5 · Cited by 1
[Audiological phenotypes of Antlet-Bixler syndrome: a case report and literatures review].
Zhao, M., Zhang, J., & Wang, Q. (2023) · PubMed Central · doi:10.13201/j.issn.2096-7993.2023.03.016 · Cited by 3
Disorders of the Adrenal Gland
Fechner, P. Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00084-2 · Cited by 1
Abderahmene, A., Francke, M. I., Ammar, M., Andrews, L. M., Hesselink, D. A., Amor, D., SAHTOUT, W., Awatif, A., Bouslama, A., Zellama, D., et al. (2025) · Personalized Medicine · doi:10.1080/17410541.2025.2606641 · Cited by 1
Li, H., Li, S., Wang, Q., & Jia, C. (2016) · Human Genetics · doi:10.1007/s00439-016-1728-9 · Cited by 1
Management of Disorders of Sex Development
Sultan, C., Gaspari, L., Kalfa, N., & Paris, F. (2017) · ISGE series · doi:10.1007/978-3-319-41433-1_2 · Cited by 1
Arboleda, V. A., & Vilain, E. J. N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00019-1 · Cited by 3
Disorders of Sexual Development
Raza, J., & Warne, G. L. (2012) · Springer eBooks · doi:10.1007/978-3-642-02202-9_383 · Cited by 1
Evaluation and Management of Disorders of Sex Development
Hughes, I. A. (2009) · Wiley eBooks · doi:10.1002/9781444316728.ch9 · Cited by 1
Gomes, L. G. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-09122009-152831
Disorders of Sexual Development
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-39256-3.50178-3
Ho, M. (2011) · TSpace (University of Toronto)
Metadata
- Authors
- Scott, R. R., & Miller, W. L.
- Affiliations
- Dalhousie University (CA)
- ORCID
- Miller, Walter L.
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 69
- Issue
- 5
- Pages
- 266-275
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2060640171
- Semantic Scholar
- 4514e0eb72f2700a24f074ea036f7d8a59450a24
- Cited by
- 115
- References
- 61
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 3 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (GM073020, R01GM073020)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- P450 oxidoreductase deficiency, steroidogenesis, 21-hydroxylase deficiency, 17α-hydroxylase/17,20-lyase deficiency, aromatase deficiency, Antley-Bixler syndrome, FGFR2, craniosynostosis, adrenal insufficiency, sex reversal, drug metabolism, autosomal recessive disorder
- MeSH terms
- Abnormalities, Multiple, Bone and Bones, Cytochrome P-450 Enzyme System, Endocrine System Diseases, Humans, Hydroxysteroid Dehydrogenases, Models, Biological, NADH, NADPH Oxidoreductases, Steroid 17-alpha-Hydroxylase, Steroid 21-Hydroxylase, Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.